There have been considerable advances in our understanding of the transmission and modulation of nociceptive messages at both the central and peripheral endings of sensory afferent fibres. This review concentrates on the evidence for plasticity in these systems and emphasizes the recent spinal electrophysiological studies on the interplay between excitatory amino acids, opioids, noradrenaline and non-opioid peptides in these events.
Get full access to this article
View all access options for this article.
References
1.
Akerman B., Arwestrom E., Post C. ( 1988) Local anesthetics potentiate spinal morphine analgesia . Anesth Analg67: 943-948
2.
Allard M., Geoffre S., Legendre P., Vincent J.D., Simonnet G. (1989) Characterization of rat spinal cord receptors to FLFQPRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res500: 169-176
3.
Arner S., Meyerson B.A. (1988) Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain33: 11-23
4.
Baber N.S., Dourish C.T., Hill D.R. (1989) The role of CCK, caerulin and CCK antagonists in nociception. Pain39: 307-328
5.
Battaglia G., Rustioni A. (1988) Coexistence of glutamate and substance P in dorsal root ganglion cells of the rat and monkey. J Comp Neurol277: 302-312
6.
Besse D., Lombard M.C., Zakac J.M., Roques B.P., Besson J.M. (1990) Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res521: 15-22
7.
Besson J.M., Chaouch A. (1987) Peripheral and spinal mechanisms of nociception . Physiol Rev67: 67-186
8.
Bliss T V P, Lynch M.A. (1988) Long term potentiation of synaptic transmission in the hippocampus: properties and mechanisms. In Long term potentiation: from biophysics to behaviour. A Liss, pp. 3-72
9.
Chang R S L, Lotti V.J. (1986) Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystokinin antagonist . Proc Natl Acad Sci USA83: 4923-4926
10.
Collingridge G., Lester R A J (1989) Excitatory amino acid receptors in the vertebrate nervous system. Pharmacol Rev40: 143-210
11.
Davies S.N., Lodge D. (1987) Evidence for involvement of N-methyl-D-aspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res424: 402-406
12.
Dickenson A.H. (1990) A cure for wind-up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci11: 307-309
13.
Dickenson A.H., Aydar E. (1991) Antagonism at the glycine on the NMDA receptor reduces spinal nociception in the rat. Neurosci Lett121: 263-266
14.
Dickenson A.H., Magnuson D S K (1989) The actions of cholecystokinin, morphine and DSTBULET in the rat spinal cord in vitro. J Physiol415: 52P
15.
Dickenson A.H., Sullivan A.F. (1986) Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn. Pain24: 211-222
16.
Dickenson A.H., Sullivan A.F. (1987) Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep dorsal horn neurones following C-fibre stimulation. Neuropharmacology26: 1235-1238
17.
Dickenson A.H., Sullivan A.F. (1989) Subcutaneous formalin induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain30: 349-360
18.
Dickenson A.H., Sullivan A.F. (1990) Differential effects of excitatory amino-acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res506: 31-39
19.
Dickenson A.H., Sullivan A.F., Fournie-Zaluski M-C., Roques B.P. (1987a) Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord. Brain Res408: 185-191
20.
Dickenson A.H., Sullivan A.F., Knox R.J., Zajac Z.M., Roques B.P. (1987b). Opioid receptor sub-types in the rat spinal cord: electrophysiological studies with μ and δ opioid receptor agonists in the control of nociception. Brain Res413: 36-44
21.
Dourish C.T., O'Neill M F., Coughlan J., Kitchener S.J., Hawley D., Iverson S.D. (1990) The selective CCK-B antagonist L-365,260 enhances morphine analgesia and prevents tolerance in the rat. Eur J Pharmacol176: 35-44
22.
Dray A. ( 1991) Analgesics of the future. Pain Soc8: 43-47
23.
Dray A., Campbell E.A., Hughes G.A., Patel I.A., Perkins M.N., Rang H.P., Rueff A., Seno N., Urban L., Walpole C S J (1991) Antagonism of capsaicin induced activation of C-fibres by a selective capsaicin antagonist, capsazepine. Br J Pharmacol (in press)
24.
Dubner R. (1991) Pain and hyperalgesia following tissue injury: new mechanisms and new treatments. Pain44: 213-214
25.
Dubuisson D., Dennis S.G. (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain4: 161-174
26.
Duggan A.W., North R.A. (1984) Electrophysiology of opioids. Pharmacol Rev35: 219-281
27.
Evans R.H. (1989) The pharmacology of segmental transmission in the spinal cord. Progr Neurobiol33: 255-279
28.
Fitzgerald M. (1990): c-Fos and the changing face of pain. Trends Neurosci13: 439-440
29.
Haley J.E., Schachter M., Dickenson A.H. (1989) Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat. Neurosci Lett97: 198-202
30.
Haley J.E., Sullivan A.F., Dickenson A.H. (1990) Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res.518: 218-226
31.
Headley P.M., Grillner S. (1990) Excitatory amino-acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol Sci11: 205-211
32.
Heyman J.S., Vaught J.L., Raffa R.B., Porreca F. (1988) Can supraspinal δ-opioid receptors mediate antinociception? Trends Pharmacol Sci9: 134-138
33.
Howe J., Yaksh T.L., Go V L W (1987) The effect of unilateral; dorsal root ganglionectomies or ventral rhizotomies on α-2 adrenoceptor binding to, and the substance P, enkephalin, and neurotensin content of, the cat lumbar spinal cord. Neuroscience21: 385-394
34.
Hunskaar S., Hole K. ( 1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain30: 103-114
35.
Kalso A., Sullivan A.F., McQuay H., Dickenson A.H. (1991) Interactions between alpha-2 adrenergic, opioid and FLQPlaRFamide influences on nociception in the rat spinal cord in vivo . J Physiol (in press)
36.
Kayser V., Benoist J.M., Neil A., Gautron M., Guilbaud G. (1988) Behavioural and electrophysiological studies on the paradoxical antinociceptive effects of an extremely low dose of naloxone in an animal model of acute and localized inflammation. Exp Brain Res73: 402-410
37.
Kellstein D.E., Price D.D., Mayer D.J. (1991) Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine induced inhibition of C-fiber evoked discharges of dorsal horn neurons. Brain Res540: 302-306
38.
Knox R.J., Dickenson A.H. (1987) Effects of selective and non-selective x opioid agonists on cutaneous C fibre evoked responses of rat dorsal horn neurones . Brain Res415: 11-19
39.
Lodge D., Johnson K.M. (1990) Noncompetitive excitatory amino acid receptor antagonists . Trends Pharmacol Sci11: 81-86
40.
Lombard M.C., Besson J.M. (1989) Attempts to gauge the relative importance of pre- and postsynaptic effects of morphine on the transmission of noxious messages in the dorsal horn of the rat spinal cord. Pain37: 335-346
41.
Magnuson D S K, Sullivan A.F., Simmonet G., Roques B.P., Dickenson A.H. (1990) Differential interactions of cholecystokinin and FLQPfaRFamide with μ and δ opioid antinociception in rat spinal cord . Neuropeptides16: 213-218
42.
McQuay H., Dickenson A.H. (1990) Implications of central nervous system plasticity for pain management. Anaesthesia45: 101-102
43.
Mendell L.M. (1966) Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol16: 316-332
44.
Millan M.J. (1990) x opioid receptors and analgesia. TrendsPharmacol Sci11: 70-76
45.
North R.A. (1989) Drug receptors and the inhibition of nerve cells . Br J Pharmacol98: 13-28
46.
Presley R.W., Menetrey D., Levine J.D., Basbaum A.I. (1990) Systemic morphine suppresses noxious stimulus-evoked fos protein-like immunoreactivity in the rat spinal cord. Neuroscience10: 323-335
47.
Price D.D., Wu J.W., Dubner R., Gracely R.H. (1977) Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain3: 57-68
48.
Ruda M.A., Iadorala M.J., Cohen L.V., Young W S III (1988) In situ hybridisation histochemistry and immunocytochemistry reveal an increase in spinal cord dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc Natl Acad Sci USA85: 622-626
49.
Schouenborg J., Dickenson A.H. (1985) The effects of a distant noxious stimulation on A- and C-fibre evoked flexion reflexes and neuronal activity in the dorsal horn of the rat. Brain Res328: 23-32
50.
Schouenborg J., Dickenson A.H. (1988) Long-lasting neuronal activity in rat dorsal horn evoked by impulses in cutaneous C fibres during noxious mechanical stimulation . Brain439: 56-63
51.
Schouenborg J., Sjolund B.H. (1983) Activity evoked by A-and C-afferent fibers in rat dorsal horn and its relation to a flexion reflex. J Neurophysiol50: 1108-1121
52.
Shaw P.J., Ince P.G., Johnson M., Perry E.K., Candy J. (1991) The quantitative autoradiographic distribution of [3H ] MK-801 binding sites in the normal human spinal cord. Brain Res539: 164-168
53.
Sher G., Mitchell D. (1990) N-Methyl-D-aspartate receptors mediate responses of rat dorsal horn neurones to hindlimb ischaemia. Brain Res522: 55-62
54.
Stein C., Millan M.J., Shippenberg T.S., Peter K., Herz A. ( 1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors . J Pharmacol Exp Ther248: 1269-1275
55.
Sullivan A.F., Dashwood M.R., Dickenson A.H. (1987) α-2 adrenoceptor modulation of nociception in rat spinal cord: location, effects and interactions with morphine. Eur J Pharmacol138: 169-177
56.
Sullivan A.F., Dickenson A.H., Roques B.P. (1989) δ-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones. Br J Pharmacol98: 1039-1049
57.
Virtanen R., Viitamaa T., Nyman L. (1988) Pharmacological properties of the enantiomers of α 2 agonist medetomidine. Psychopharmacology96: Suppl. 371
58.
Wang X-J., Han J-S. (1990) Modification by cholecystokinin octapeptide of the binding of μ-, δ- and x-opioid receptors. J Neurochem55: 1379-1382
59.
Watkins J.C., Krogsgaard-Larsen P., Honore T. (1990) Structure-activity relationships in the development of excitatory amino acid agonists and competitive antagonists. Trends Pharmacol Sci11: 25-33
60.
Watkins L.R., Kinsheck I.B., Mayer D.J. (1984) Potentiation of morphine analgesia and apparent reversal of morphine tolerance by proglumide. Science224: 395-396
61.
Watkins L.R., Kinsheck I.B., Kaufman E F S, Miller J., Frenk H., Mayer D.J. (1985) Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. Brain Res327: 181-190
62.
Weisenfeld-Hallin Z., Duranti R. (1987) Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the flexion reflex in the rat. Peptides8: 153-158
63.
Willetts J., Balster R.L., Leander D. (1990) The behavioral pharmacology of NMDA receptor antagonists . Trends Pharmacol Sci11: 423-428
64.
Williams R.G., Dimaline R., Varo A., Isetta A.M., Trizio D., Dockray G.J. (1987) Cholecystokinin octapeptide in the rat central nervous system: immunohistochemical studies using a monoclonal antibody that does not react with CGRP. Neurochem Int11: 433-441
65.
Wisden W., Errington M.L., Williams S., Dunnett S.B., Waters C., Ditchcock D., Evan G., Bliss T V P, Hunt S.P. (1990) Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron4: 603-614
66.
Woolf C.J. (1983) Evidence for a central component of post-injury pain hypersensitivity. Nature221: 313-328
67.
Woolf C.J., Wall P.D. (1986) Morphine sensitive and morphine insensitive actions of C-fibre input on the rat spinal cord. Neurosci Lett64: 221-225
68.
Woolf C.J., Thompson S W N (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury hypersensitivity states. Pain44: 293-299
69.
Yaksh T.L. (1989) Behavioural and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain37: 111-123
70.
Yaksh T.L., Furai T. (1990) Release of cholecystokinin-like immunoreactivity from rat cerebral cortex and spinal cord: modulatory effect of excitatory and inhibitory amino acids. In Hughes J, Dockray G, Woodruff G (eds), The neuropeptide cholecystokinin (CCK) anatomy and physiology . Ellis Horwood, Chichester, pp. 81-90
71.
Yaksh T.L., Nouiehed R. (1985) Physiology and pharmacology of spinal opiates. Annu Rev Pharmacol Toxicol25: 433-462
72.
Yaksh T.L., Eustaquio O.A., Go V L W (1982) Studies on the location of release of cholecystokinin and vasoactive intestinal polypeptide in rat and cat spinal cord. Brain Res242: 279-290
73.
Yaksh T.L., Al-Rodhan N R F, Jensen T.S. (1988) Sites of action of opiates in the production of analgesia. In Fields H L, Besson J-M (eds), Progress in brain research , Elsevier, Amsterdam, pp. 371-394
74.
Zajac J-M., Lombard M-C., Peschanski M., Besson J-M., Roques B.P. (1989) Autoradiographic study of μ and δ opioid binding sites and neutral endopeptidase in rat after dorsal root rhizotomy . Brain Res500: 169-176
